Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Liquidia Corporation - Common Stock
(NQ:
LQDA
)
72.10
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 13, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Liquidia Corporation - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Why Liquidia Stock Was Diving This Week
↗
Today 1:07 EDT
It needed to post a blowout quarter instead of the good one it delivered.
Via
The Motley Fool
Liquidia Q2 Earnings Call Highlights
↗
August 12, 2026
Liquidia (NASDAQ:LQDA) reported second-quarter 2026 results marked by continued growth for its inhaled treprostinil product YUTREPIA, increased profitability and expanding investment in its clinical...
Via
MarketBeat
Topics
Earnings
Liquidia Corp (NASDAQ:LQDA) Shows High Growth Momentum With a Breakout Setup
↗
August 12, 2026
Via
Chartmill
Liquidia Corporation Reports Second Quarter 2026 Financial Results
August 12, 2026
From
Liquidia Technologies, Inc.
Via
GlobeNewswire
Liquidia Corporation to Report Second Quarter 2026 Financial Results on August 12, 2026
July 29, 2026
From
Liquidia Technologies, Inc.
Via
GlobeNewswire
LIQUIDIA CORP (NASDAQ:LQDA): A High Growth Stock with a Strong Technical Setup
↗
July 28, 2026
Via
Chartmill
Liquidia Corp (NASDAQ:LQDA): An Affordable Growth Stock With Explosive Revenue Momentum and Reasonable Forward Valuation
↗
July 20, 2026
Via
Chartmill
Liquidia Corp. (NASDAQ:LQDA) Flashes Perfect 10/10 Technical Score on Minervini Trend Template and High Growth Momentum
↗
June 18, 2026
Via
Chartmill
Transcript: Liquidia Q1 2026 Earnings Conference Call
↗
June 26, 2026
Liquidia (NASDAQ:LQDA) released first-quarter financial results and hosted an earnings call on Monday. Read the complete transcript below. Benzinga APIs provide real-time access to earnings call...
Via
Benzinga
Topics
Earnings
Liquidia Announces Poster Presentations at the PHA 2026 International PH Conference and Scientific Sessions
June 11, 2026
From
Liquidia Technologies, Inc.
Via
GlobeNewswire
Liquidia Corp (NASDAQ:LQDA): Affordable Growth Play With Explosive Revenue
↗
June 10, 2026
Via
Chartmill
Liquidia Corporation Announces Inclusion in the S&P SmallCap 600® Index
June 08, 2026
From
Liquidia Technologies, Inc.
Via
GlobeNewswire
Liquidia Corporation to Present at 2026 Jefferies Global Healthcare Conference
May 27, 2026
From
Liquidia Technologies, Inc.
Via
GlobeNewswire
Liquidia Corp (NASDAQ:LQDA) Smashes Q1 Estimates as YUTREPIA Adoption Accelerates
↗
May 11, 2026
Via
Chartmill
Liquidia Corp (NASDAQ:LQDA): High Growth Momentum Setup Nears Breakout
↗
April 27, 2026
Via
Chartmill
Liquidia Corp (NASDAQ:LQDA) Presents a High-Growth Momentum and Technical Setup
↗
April 03, 2026
Via
Chartmill
Liquidia Corp (NASDAQ:LQDA) Shows High-Growth Momentum and Minervini Trend Alignment
↗
March 11, 2026
Via
Chartmill
What to Know About This Fund’s $15.5 Million Sale of Liquidia as Shares Skyrocket Nearly 260%
↗
May 13, 2026
Liquidia develops therapies for rare cardiopulmonary diseases, leveraging proprietary drug delivery technologies in the U.S. market.
Via
The Motley Fool
Liquidia (LQDA) Q1 2026 Earnings Transcript
↗
May 11, 2026
Liquidia (LQDA) Q1 2026 Earnings Transcript
Via
The Motley Fool
Liquidia Q1 Earnings Call Highlights
↗
May 11, 2026
Liquidia (NASDAQ:LQDA) reported sharply higher first-quarter 2026 sales and profitability as executives said the launch of YUTREPIA continued to gain traction in pulmonary arterial hypertension and...
Via
MarketBeat
Topics
Earnings
Liquidia Corporation Reports First Quarter 2026 Financial Results
May 11, 2026
From
Liquidia Technologies, Inc.
Via
GlobeNewswire
This Biotech Stock Has Soared 175%. Here’s Why One Fund Still Sold $3 Million Worth
↗
May 09, 2026
This biotech firm develops therapies for rare pulmonary diseases, leveraging proprietary drug delivery technology in the U.S. market.
Via
The Motley Fool
Topics
Regulatory Compliance
Liquidia Corporation to Participate in Upcoming Investor Conferences
May 06, 2026
From
Liquidia Technologies, Inc.
Via
GlobeNewswire
Liquidia Corporation to Report First Quarter 2026 Financial Results on May 11, 2026
May 04, 2026
From
Liquidia Technologies, Inc.
Via
GlobeNewswire
Liquidia's (LQDA) CEO Sells 53,000 Shares for $2.1 Million
↗
April 19, 2026
Biotech innovator Liquidia, specializing in pulmonary therapies, reported a notable insider sale amid continued growth in its core market.
Via
The Motley Fool
Topics
Regulatory Compliance
Liquidia Corporation to Participate in Upcoming Investor Conferences
April 07, 2026
From
Liquidia Technologies, Inc.
Via
GlobeNewswire
Liquidia's Chairman Sold Company Shares Worth $2.5 Million. Should Investors Avoid the Stock?
↗
April 05, 2026
This biotech focused on pulmonary therapies reported a notable insider sale amid strong share price gains and rising revenue.
Via
The Motley Fool
Topics
Regulatory Compliance
The Chief Commercial Officer of Liquidia (LQDA) Sold 80,000 Shares for $2.8M
↗
March 28, 2026
Biotech innovator Liquidia, focused on therapies for rare conditions, reported a notable insider sale amid strong recent share performance.
Via
The Motley Fool
Topics
Regulatory Compliance
Liquidia Stock Up 135% as Insider Sells $1.3 Million in Shares
↗
March 24, 2026
This biotech innovator in rare disease therapies reported significant insider selling amid a year of robust stock performance.
Via
The Motley Fool
Topics
Regulatory Compliance
Dave Stock Soars 150% in a Year as Newly Disclosed $7 Million Buy Signals Confidence in Fintech Upstart
↗
March 12, 2026
Dave Inc. delivers digital banking and personal finance tools designed to offer alternatives to traditional banking platforms.
Via
The Motley Fool
Topics
ETFs
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.